It has been proposed that mannose-binding lectin (MBL) interactions with agalactosyl forms of IgG immunoglobulins found in rheumatoid synovial fluid might lead to enhanced complement activation, an important mediator of the joint damage in rheumatoid arthritis (RA). In order to investigate this possible link between increased MBL-mediated activation of complement and perpetuation of rheumatoid synovitis, we have compared the frequency of an allelic form of MBL, known to be incapable of activating complement, in a group of hospital patients with severe RA and control subjects. No evidence was found to support an association between the presence of this MBL allele and protection from rheumatoid disease; genotype frequencies were similar in both groups. This suggests that complement activation via MBL-agalactosyl IgG complexes is unlikely to play a major role in the pathophysiology of RA.
L activation of complement may play a role in of the wild-type level ) and function [5] . We have, therefore, addressed this hypothesis by determining the mediating synovial inflammation in rheumatoid arthfrequency of this mutation in a well-characterized ritis (RA) ( [1] and references within). Synovial fluid hospital RA population, and by assessing any associin RA contains high concentrations of immunoation with disease severity. globulins and rheumatoid factors which, through their ability to form immune complexes, may promote com-PATIENTS AND METHODS plement activation. In addition, distinctive glycosyl-A total of 181 Caucasian hospital rheumatology ation patterns of these synovial immunoglobulins have out-patients with RA, satisfying American Rheubeen reported, including a raised proportion of IgG matism Association criteria, were classified in terms immunoglobulins which contain galactose-deficient oligoof sex, age of onset, seropositivity for rheumatoid saccharides [2, 3] . Of potential significance for the factor ( RF ) and the presence or absence of rheumatoid pathogenesis of RA is the demonstration that these nodules. Control groups were drawn from university agalactosyl IgG glycoforms, which now terminate in and hospital staff, and from subjects attending their N-acetylglucosamine, become accessible for binding to general practitioner, as discussed previously [7] . mannose-binding lectin (MBL) [4] . This protein Extraction of genomic DNA from peripheral blood (MBL), which is found in the synovial fluid of patients leucocytes has been described previously [8] . Codon with RA, is capable of binding strongly to glycoprotein 54 genotyping was performed by restriction fragment molecules terminating in mannose or N-acetylglucoslength polymorphism-polymerase chain reaction amine, and can mediate opsonization and classical (RFLP-PCR), as described by Lipscombe et al.
[9]: complement pathway activation, the latter by a route the first exon of the MBL gene was amplified by PCR which is independent of Clq [5] .
(primers MBL1 and MBL2; [8] ) and the product then In view of this possible link between agalactosyl incubated with the restriction enzyme BanI, which IgG, increased MBL-mediated activation of complethrough its unique cleavage site permits identification ment and the perpetuation of rheumatoid synovitis, of this mutation. Ten-microlitre digests were performed we, and others [6 ] , have hypothesized that lower levels by the incubation of 8 ml of PCR product with 5 U of and activity of MBL might, in this situation, be
BanI at 50°C for 1 h. Genotyping was determined protective against rheumatoid disease. The single MBL directly by visualizing the digested products on a 1.5% gene (Mbl ) in man is located on the long arm of agarose gel stained with ethidium bromide. Because of chromosome 10, and has four exons. In Caucasians, concerns that the primers used in this assay may the major genetic determinant of serum MBL is a overestimate the frequency of codon 54 homozygous single point mutation within codon 54 of the first exon, mutants (see [10]), we repeated the typing using a which has a gene frequency between 0.11 and 0.17 [5, second forward primer, offset 5∞ from the support an association between an allele of the MBL gene which is known to have impaired ability to activate complement and protection from RA. MBL MBL codon 54 mutation was found to be similar in genotype frequencies were similar between the rheumthe groups of control subjects and in patients with atoid study group and controls. Assessing whether the RA. No evidence was found to suggest a decrease in MBL codon 54 mutation conferred protection from the frequency of the codon 54 mutation in the rheumatmore severe disease in RA was complicated by the oid study group. difficulty of defining parameters of disease severity for The results describing the analysis of phenotype this group of patients. The individuals with RA were frequencies in relation to indicators of the disease in derived from a hospital group, and tend towards the this hospital-based population of RA patients are more severe end of the clinical spectrum. A total of shown in Table II . No statistical differences between 60% of the RA group were also DR4 positive, an HLA these subsets of RA and the frequency of the MBL Class II allele known to be associated with more severe codon 54 mutation allele were observed. It might be forms of the disease [1] . Moreover, the MBL mutant considered that MBL-mediated complement activation allele was found in certain individuals whose HLAwould be masked in RF-positive individuals who, DR4 subtypes were typed as DRB1 0401/0404, a dual through immune complex formation, have an addigenotype reported to be strongly associated with severe tional pathway promoting complement activation; in disease ( [1] ; data not shown). There was finally no such a case, a protective role for MBL deficiency might relationship between the presence of the codon 54 be uncovered by further subgroup analysis of mutation allele and other indicators of severe rheumat-RF-negative patients. However, in RF-negative indioid disease, such as RF ( Table II ) . Taken together, viduals, the same relative proportions of MBL genothis study suggests that MBL deficiency does not types were found as for controls (data not shown).
protect against severe RA. Similar conclusions have been reported in a recent study of MBL protein levels DISCUSSION in the sera of RA patients [13]; however, interpretation There is increasing recognition that the protein MBL of MBL protein in sera is complicated by the variability may be an important component of the innate immune of levels, MBL being an acute-phase protein. system, part of the non-specific protective response to
The codon 54 genotype is the most significant known infection. It is primarily a serum acute-phase protein, genetic predictor of serum MBL levels in Caucasians, which can bind to the large numbers of sugar targets although levels in wild-type individuals can show wide found on microbial cell surfaces; indeed, there is evidvariation [5] . The data cannot, therefore, exclude a ence suggesting that deficiency of the protein may be role for other MBL polymorphisms in susceptibility to associated with a predisposition to infection [11, 12] . and severity of RA, including the codon 52 and 57 However, the exact nature of this relationship with gene mutations (more prevalent in Africa), or in the 5∞ susceptibility to infection remains unclear [7] .
promoter regulatory regions of the gene. A study of Moreover, population studies have revealed an unexserum MBL levels in a second smaller group of RA pectedly high frequency of structural MBL gene mutapatients (N. Snowden and M. W. Turner, unpublished tions, which significantly reduce serum levels of the data) has also failed to demonstrate any significant protein. It has been suggested that this may reflect, by difference with controls, consistent with the results of contrast, a selection advantage for reduced activities of MBL-associated immune mechanisms, such that, this genetic study. In summary, this study indicates 
